Dr. Reddy's Laboratories hits 52-week low as its consolidated net profit drops 69% in Q1
Dr. Reddy's Laboratories is currently trading at Rs. 1149.65, down by 33.35 points or 2.82% from its previous closing of Rs. 1183.00 on the BSE.
The scrip opened at Rs. 1080.05 and has touched a high and low of Rs. 1163.00 and Rs. 1080.05 respectively. So far 245234 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1414.40 on 29-Jun-2026 and a 52 week low of Rs. 1,080.05 on 23-Jul-2026.
Last one week high and low of the scrip stood at Rs. 1,233.35 and Rs. 1,080.05 respectively. The current market cap of the company is Rs. 96229.77 crore.
The promoters holding in the company stood at 26.64%, while Institutions and Non-Institutions held 52.40% and 9.55% respectively.
Dr. Reddy's Laboratories has reported an 86.33% decline in its standalone net profit at Rs 404.70 crore for the first quarter ended June 30, 2026 (Q1FY27), as compared to Rs 2,961.20 crore for the same quarter in the previous year. Total income declined by 32.05% to Rs 5,577.00 crore for Q1FY27 as compared to Rs 8,207.80 crore for the corresponding quarter of the previous year.
On a consolidated basis, the company has reported a 68.67% decline in its net profit at Rs 444.30 crore for Q1FY27, as compared to Rs 1,418.10 crore for the same quarter in the previous year. Total income declined by 4.60% to Rs 8,454.50 crore for Q1FY27 as compared to Rs 8,862.40 crore for the corresponding quarter of the previous year.
